Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

PBOC Signals No Urgency for Rate Cuts Despite China’s Worst Economic Month of 2025

by Team Lumida
August 18, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Central Bank Embraces Hedge Fund Tactics to Tame $4 Trillion Bond Market

"China's flag" by futureatlas.com is licensed under CC BY 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • The People’s Bank of China pledged to “thoroughly” enact its “moderately loose” monetary policy while emphasizing targeted rather than broad-based easing measures.
  • Major banks including Citigroup and Goldman Sachs believe the PBOC will delay interest rate cuts and reserve requirement ratio reductions until later this year.
  • China’s economy stumbled in July due to overcapacity campaigns, higher tariffs, and weaker infrastructure and consumption stimulus, revealing fragile private demand.
  • Despite challenges, the PBOC said the economy’s foundation remains solid with strong resilience, noting improvement in core CPI excluding volatile food and energy.
  • With 5.3% GDP growth in H1 2025, China can likely tolerate slower H2 growth and still meet the official ~5% annual target.
  • The central bank highlighted concerns about funds “idly circulating” in the financial system, indicating focus on financial stability over aggressive easing.
  • Economists expect a 10-20 basis point rate cut and 50 basis point RRR reduction by year-end, with potential 500 billion yuan fiscal stimulus if conditions worsen.
  • The PBOC established a macro-prudential and financial stability committee in January, expanding its mandate beyond traditional monetary policy.

What’s Happening?

China’s central bank is taking a cautious approach to monetary easing despite July’s economic weakness, preferring targeted measures over broad stimulus. The PBOC appears confident that current growth momentum can sustain the annual target without aggressive intervention. The bank is balancing growth support with financial stability concerns, particularly regarding speculative fund flows within the banking system.

Why Does It Matter?

The PBOC’s restraint suggests confidence in China’s economic resilience and indicates policy makers are saving monetary ammunition for potential future downturns. The approach reflects lessons from previous stimulus cycles that created asset bubbles and debt concerns. The central bank’s expanded mandate into financial stability shows Beijing’s focus on systemic risk management alongside growth objectives, potentially influencing global commodity and currency markets.

What’s Next?

Markets will watch for signs of economic deterioration that might force the PBOC to accelerate easing measures. The effectiveness of targeted policies versus broad stimulus will be tested as trade tensions and domestic demand challenges persist. Fiscal authorities may need to step up if monetary policy remains restrained and growth momentum weakens further.

Source
Previous Post

US-Sanctioned Russian LNG Tankers Head to Asia Seeking Buyers Amid Ukraine Talks

Next Post

European Exports to US Plunge 10% in June as Trump Tariffs Bite Trade Relations

Recommended For You

Obamacare Insurers Face Political Attacks Just as Their Margins Collapse

by Team Lumida
6 hours ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key Takeaways Powered by lumidawealth.com President Trump is attacking ACA insurers as profiteers and backing Republican plans to redirect subsidies from insurers to consumers. In reality, many Affordable Care...

Read more

Why the ‘Affordability Crisis’ Is Real Politics but Not a Fixable Macro Problem

by Team Lumida
6 hours ago
Why the ‘Affordability Crisis’ Is Real Politics but Not a Fixable Macro Problem

Key Takeaways The so-called affordability crisis is less about current inflation and more about a diffuse set of micro-level price pressures that vary by person, place, and time....

Read more

U.S.–Ukraine Peace Plan Edges Forward, but Key Fault Lines With Russia and Europe Remain

by Team Lumida
6 hours ago
Trump Suggests $2,000 Tariff-Funded Payouts to Americans

Key Takeaways The White House and Ukraine agreed in Geneva on an “updated and refined” U.S.-proposed peace framework, while acknowledging key issues remain unresolved. Kyiv is pushing to...

Read more

US Retail Sales Hold Firm, but Cracks in Consumer Confidence Are Growing

by Team Lumida
1 day ago
US Retail Sales Hold Firm, but Cracks in Consumer Confidence Are Growing

Key Takeaways Powered by lumidawealth.com September US retail sales are expected to rise 0.4%, signaling continued—though moderating—consumer resilience. Spending strength is increasingly concentrated among higher-income households benefiting from market...

Read more

Fed Split Deepens: Why Internal Divisions, Not Just Powell, Threaten Lower Rates and Central Bank Independence

by Team Lumida
2 days ago
Powell’s Pivotal Moment: What to Expect from Jackson Hole

Key Takeaways Powered by lumidawealth.com Powell faces the most internal resistance of his tenure over a potential December rate cut, with multiple dissents likely either way. Growing divisions show...

Read more

China Escalates “Pen and Gun” Pressure Campaign on Taiwan — Cultural Indoctrination at Home, Coercion Abroad

by Team Lumida
4 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com Beijing is intensifying a dual strategy—“the pen and the gun”—combining state-driven propaganda with coercive geopolitical moves to isolate Taiwan. China is running a new...

Read more

Trump Signs Bill Requiring Release of Epstein Files — DOJ Has 30 Days to Publish Unclassified Records

by Team Lumida
4 days ago
Trump Suggests $2,000 Tariff-Funded Payouts to Americans

Key Takeaways Powered by lumidawealth.com President Trump signed legislation mandating the Justice Department release unclassified Jeffrey Epstein files within 30 days. The bill passed the House 427–1 and cleared...

Read more

Bill Ackman Says Treasury Should Delay Fannie/Freddie Sale — Pushes for Warrant Exercise and NYSE Relisting First

by Team Lumida
5 days ago
Bill Ackman Says Treasury Should Delay Fannie/Freddie Sale — Pushes for Warrant Exercise and NYSE Relisting First

Key Takeaways Powered by lumidawealth.com Bill Ackman argues it is not the right time for the US Treasury to sell its Fannie Mae and Freddie Mac stakes. He proposes...

Read more

Labor Dept. Accidentally Releases Key Jobless-Claims Data Ahead of Thursday’s Post-Shutdown Jobs Report

by Team Lumida
5 days ago
Labor Dept. Accidentally Releases Key Jobless-Claims Data Ahead of Thursday’s Post-Shutdown Jobs Report

Key Takeaways Powered by lumidawealth.com A technical error caused the Labor Department to accidentally publish one of the missing jobless-claims datapoints from the shutdown period. 232,000 new unemployment claims...

Read more

Congress Sounds Alarm: China’s Deepening Control Over US Drug Supply Poses National Security Risk

by Team Lumida
6 days ago
U.S. Struggles to Break China’s Grip on Critical Minerals as Syrah Resources Faces Setbacks

Key Takeaways Powered by lumidawealth.com China supplies key ingredients for roughly 25% of generic drugs used in the US—including some produced exclusively in China. A congressional report warns that...

Read more
Next Post
blue and red cargo ship on sea during daytime

European Exports to US Plunge 10% in June as Trump Tariffs Bite Trade Relations

Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Trump Pushes Three-Way Summit With Putin and Zelensky as Europeans Shape Ukraine Peace Terms

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Capgemini Partners with SAP and Mistral AI to Deliver Generative AI Solutions for Regulated Industries

Capgemini Partners with SAP and Mistral AI to Deliver Generative AI Solutions for Regulated Industries

May 27, 2025
Microsoft’s AI Ambitions: A Costly Path Forward

Microsoft Urges Trump Administration to Ease AI Chip Export Restrictions Amid Global Competition

February 27, 2025
Fed Official Warns of Inflation Risks Under Trump Presidency

Markets Rally on Trump’s China Trade Signals; Global Stocks Rise Despite US Holiday

January 20, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018